Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

450 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment with recombinant human erythropoietin (rHuEpo) in a patient with paroxysmal nocturnal haemoglobinuria: evaluation of membrane proteins CD55 and CD59 with cytofluorometric assay.
Astori C, Bonfichi M, Pagnucco G, Bernasconi P, Lazzarino M, Orlandi E, Bernasconi C. Astori C, et al. Among authors: bernasconi c, bernasconi p. Br J Haematol. 1997 Jun;97(3):586-8. doi: 10.1046/j.1365-2141.1997.912908.x. Br J Haematol. 1997. PMID: 9207404 Free article.
Randomized clinical study comparing aggressive chemotherapy with or without G-CSF support for high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia evolving from MDS.
Bernasconi C, Alessandrino EP, Bernasconi P, Bonfichi M, Lazzarino M, Canevari A, Castelli G, Brusamolino E, Pagnucco G, Castagnola C. Bernasconi C, et al. Among authors: bernasconi p. Br J Haematol. 1998 Aug;102(3):678-83. doi: 10.1046/j.1365-2141.1998.00816.x. Br J Haematol. 1998. PMID: 9722293 Free article. Clinical Trial.
The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders.
Lazzarino M, Orlandi E, Baldanti F, Furione M, Pagnucco G, Astori C, Arcaini L, Viglio A, Paulli M, Gerna G, Bernasconi C. Lazzarino M, et al. Among authors: bernasconi c. Br J Haematol. 1999 Dec;107(4):877-82. doi: 10.1046/j.1365-2141.1999.01765.x. Br J Haematol. 1999. PMID: 10606897 Free article.
Long-term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance.
Bernasconi P, Cavigliano PM, Boni M, Astori C, Calatroni S, Giardini I, Rocca B, Caresana M, Crosetto N, Lazzarino M, Bernasconi C. Bernasconi P, et al. Among authors: bernasconi c. Br J Haematol. 2002 Aug;118(2):545-9. doi: 10.1046/j.1365-2141.2002.03651.x. Br J Haematol. 2002. PMID: 12139743 Free article.
World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
Bernasconi P, Klersy C, Boni M, Cavigliano PM, Calatroni S, Giardini I, Rocca B, Zappatore R, Caresana M, Dambruoso I, Lazzarino M, Bernasconi C. Bernasconi P, et al. Among authors: bernasconi c. Br J Haematol. 2007 May;137(3):193-205. doi: 10.1111/j.1365-2141.2007.06537.x. Br J Haematol. 2007. PMID: 17408458 Free article.
Therapy of essential thrombocythemia with alpha-interferon: results and prospects.
Lazzarino M, Vitale A, Morra E, Gagliardi A, Bernasconi P, Torromeo C, Inverardi D, Burgio VL, Castello A, Bernasconi C, et al. Lazzarino M, et al. Among authors: bernasconi c, bernasconi p. Eur J Haematol Suppl. 1990;52:15-21. doi: 10.1111/j.1600-0609.1990.tb00899.x. Eur J Haematol Suppl. 1990. PMID: 2279539 Review.
450 results